Anti-mouse CD4-InVivo

目录号:A2101         批次号: A210125

       克隆号:GK1.5

打印

Anti-mouse CD4 (克隆号:GK1.5)可与小鼠CD4结合反应。CD4是T细胞受体(TCR)的协同受体,有助于后续与抗原呈递细胞的交流通讯。

抗体信息

克隆号 GK1.5
免疫原

Mouse CTL clone V4

配制 PBS buffer, pH 6.5
推荐同型对照 Rat IgG2b,κ
应用 In vivo CD4+ T cell depletion,FCM,WB
储存条件
(自收到货起)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
除菌 0.2 μM filtered
纯度 99%
蛋白浓度 7.69 mg/ml
内毒素 <1EU/mg

客户使用selleck产品的实验数据

Anti-mouse CD4-InVivo在文献中得到引用

Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction [ Signal Transduct Target Ther, 2025, 10(1):161] PubMed: 40374605
LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation [ Cell Discov, 2025, 11(1):84] PubMed: 41162356
Silencing PCSK9 reshapes the spatiotemporal activation of STING for safe and effective cancer immunotherapy [ Nat Commun, 2025, 10.1038/s41467-025-66630-x] PubMed: 41290746
Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity [ Nat Commun, 2025, 16(1):3546] PubMed: 40229277
BET inhibitor in combination with BCG vaccine enhances antitumor efficacy and orchestrates T cell reprogramming for melanoma [ Cell Rep Med, 2025, 6(3):101995] PubMed: 40107246
CD47 antibody-armed oncolytic adenovirus promotes chimeric antigen receptor macrophage phagocytosis and antitumor immunity [ Exp Hematol Oncol, 2025, 14(1):106] PubMed: 40814015
FLT3L combined with GM-CSF induced dendritic cells drive broad tumor-specific CD8+ T cell responses and remodel the tumor microenvironment to enhance anti-tumor efficacy [ Front Immunol, 2025, 16:1649891] PubMed: 40977690
DOCK2 protects against bacterial sepsis by constraining T helper 1 response [ Front Immunol, 2025, 16:1527934] PubMed: 40510337
Dual impacts of serine/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation [ Cell Metab, 2024, S1550-4131(24)00415-7] PubMed: 39577415
Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 high-pathogenicity avian influenza virus with reduced adverse reactions [ Mol Ther, 2024, S1525-0016(24)00831-1] PubMed: 39690742

禁止用于人体及治疗!